GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Change In Receivables

Sonoscape Medical (SZSE:300633) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Change In Receivables?

Sonoscape Medical's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Sonoscape Medical's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Sonoscape Medical's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-71 Mil. It means Sonoscape Medical's Accounts Receivable increased by ¥71 Mil from Dec. 2022 to Dec. 2023 .

Sonoscape Medical's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥170 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sonoscape Medical's Days Sales Outstanding for the three months ended in Mar. 2024 was 32.39.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sonoscape Medical's liquidation value for the three months ended in Mar. 2024 was ¥1,614 Mil.


Sonoscape Medical Change In Receivables Historical Data

The historical data trend for Sonoscape Medical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Change In Receivables Chart

Sonoscape Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.65 89.20 0.46 -6.35 -71.01

Sonoscape Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sonoscape Medical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sonoscape Medical  (SZSE:300633) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sonoscape Medical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=170.143/479.334*91
=32.39

2. In Ben Graham's calculation of liquidation value, Sonoscape Medical's accounts receivable are only considered to be worth 75% of book value:

Sonoscape Medical's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1963.743-787.306+0.75 * 170.143+0.5 * 619.199
=1,614

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sonoscape Medical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical (SZSE:300633) Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.

Sonoscape Medical (SZSE:300633) Headlines

No Headlines